The Use of Linezolid in the Treatment of Infected Total Joint Arthroplasty

Journal of Arthroplasty

Volumn 23, Issue 2, 2008, Pages 273-278

  Oussedik, Sam I S ^a   Haddad, Fares S ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

infected arthroplasty; linezolid; revision arthroplasty

Indexed keywords

LINEZOLID; TEICOPLANIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENTEROCOCCUS; FEMALE; FOLLOW UP; HUMAN; JOINT PROSTHESIS; LOADING DRUG DOSE; MALE; OUTCOME ASSESSMENT; PANCYTOPENIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; TREATMENT DURATION;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; REOPERATION; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 38949113199     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2007.03.022     Document Type: Article

References (27)

1. Bernard L., Hoffmeyer P., Assal M., et al. Trends in thetreatment of orthopaedic prosthetic infections. J Antimicrob Chemother 53 (2004) 127
2. Blom A.W., Taylor A.H., Pattison G., et al. Infection after total hip arthroplasty: the Avon experience. J Bone Joint Surg Br 85-B (2003) 956
3. Blom A.W., Brown J., Taylor A.H., et al. Infection aftertotal knee arthroplasty. J Bone Joint Surg Br 86-B (2004) 688
4. Steckelberg J.M., and Osmon D.R. Prosthetic joint infections. In: Bisno A.L., and Waldgovel F.A. (Eds). Infections associated with indwelling medical devices. 3rd ed. (2000), American Society for Microbiology, Washington (DC) 173
5. McPherson E.J., Tontz Jr. W., Patzakis M., et al. Outcome of infected total knee utilizing a staging system for prosthetic joint infection. Am J Orthop 28 (1999) 161
6. McPherson E.J., Woodson C., Holtom P., et al. Periprosthetic total hip infection-outcomes using a staging system. Clin Orthop 403 (2002) 8
7. Bozdogan B., and Appelbaum P.C. Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 23 (2004) 113
8. Wilson P. Linezolid: a newantibiotic for gram-positive infections. Hosp Med 62 (2001) 682
9. Lovering A.M., Zhang J., Bannister G.C., et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 50 (2002) 73
10. Kutscha-Lissberg F., Hebler U., Muhr G., et al. Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrob Agents Chemother 47 (2003) 3964
11. Green S.L., Maddox J.C., and Huttenbach E.D. Linezolid and reversible myelosuppression. JAMA 285 (2001) 1291
12. Abena P.A., Mathieux V.G., Schieff J.M., et al. Linezolid and reversible myelosuppression. JAMA 286 (2001) 1973
13. Waldrep T.W., and Skiest D.J. Linezolid-induced anaemia and thrombocytopenia. Pharmacotherapy 22 (2002) 109
14. Attassi K., Hershberger E., Alam R., et al. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 34 (2002) 695
15. Halpern M. Linezolid associated pancytopenia. Clin Infect Dis 35 (2002) 347
16. Gerson S.L., Kaplan S.L., and Bruss J.B. Haematological effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 46 (2002) 2723
17. Rao N., Ziran B.H., Hall R.A., et al. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop 427 (2004) 67
18. Chien J.W., Kucia M.L., and Salata R.A. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin Infect Dis 30 (2000) 146
19. Rao N., Ziran B.H., Wagener M.M., et al. Similar haematological effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopaedic infections. Clin Infect Dis 38 (2004) 1058
20. Razonable R.R., Osmon D.R., and Steckelberg J.M. Linezolid therapy for orthopaedic infections. Mayo Clin Proc 79 (2004) 1137
21. Senneville E., Legout L., Valette M., et al. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J Antimicrob Chemother 54 (2004) 798
22. Youngman J.R., Ridgway G.L., and Haddad F.S. Antibiotic-loaded cement in revision joint replacement. Hosp Med 64 (2003) 613
23. Wilcox M., Nathwani D., and Dryden M. Linezolid compared with teicoplanin for the treatment of suspected or proven gram-positive infections. J Antimicrob Chemother 53 (2004) 335
24. Mutnick A.H., Enne V., and Jones R.N. Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program. Ann Pharmacother 37 (2003) 909
25. Wilson P., Andrews J.A., Charlesworth R., et al. Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 51 (2003) 186
26. Willke R.J., Glick H.A., Li J.Z., et al. Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis. Int J Technol Assess Health Care 18 (2002) 540
27. Nathwani D. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital staymatter?. J Antimicrob Chemother 51 Suppl 2 (2003) 37